Related Experiment Videos
Lipoprotein heterogeneity in end-stage renal disease
Kidney International
|February 1, 1993
Summary
Patients undergoing hemodialysis often have abnormal lipid profiles, including high triglycerides and low HDL cholesterol. These changes, linked to increased atherosclerosis risk, are not typically detected by standard lab tests.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Clinical Biochemistry
Background:
- Patients with end-stage renal disease (ESRD) on maintenance hemodialysis exhibit a high prevalence of premature atherosclerosis.
- Dyslipidemia is common in ESRD patients, but its specific lipoprotein abnormalities require further characterization.
- Standard laboratory evaluations may not fully capture the complex lipid profile alterations in these patients.
Purpose of the Study:
- To investigate and characterize lipoprotein abnormalities in chronic hemodialysis patients.
- To compare lipid profiles between hypertriglyceridemic and normotriglyceridemic hemodialysis patients.
- To assess the potential atherogenic implications of these dyslipidemias in ESRD.
Main Methods:
- Arbitrary division of 15 hemodialysis patients into hypertriglyceridemic (N=7) and normotriglyceridemic (N=8) groups.
- Analysis of fasting plasma triglyceride levels.
- Quantification of high-density lipoprotein (HDL) cholesterol.
- Measurement of post-heparin plasma lipoprotein lipase activity.
- Density gradient ultracentrifugation to analyze lipoprotein fractions.
- Assessment of low-density lipoprotein (LDL) and HDL size and composition.
Main Results:
- Hypertriglyceridemic patients showed decreased HDL cholesterol and reduced post-heparin lipoprotein lipase activity compared to normotriglyceridemic patients.
- All lipoprotein fractions were triglyceride-enriched in hypertriglyceridemic patients.
- Both groups exhibited elevated intermediate-density lipoprotein (IDL) levels, LDL heterogeneity, and abnormal HDL subpopulations.
- LDL and HDL particles displayed abnormalities in size and composition, more pronounced in hypertriglyceridemic patients.
- These detailed alterations are not detectable by routine laboratory lipoprotein analysis.
Conclusions:
- Chronic hemodialysis patients, particularly those with hypertriglyceridemia, present complex lipoprotein abnormalities.
- These dyslipidemias involve triglyceride enrichment, altered HDL and LDL characteristics, and are more severe than typically assessed.
- The identified lipoprotein alterations are likely atherogenic and contribute to the elevated risk of premature atherosclerosis in ESRD.